When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CBAY - B. Riley sees 144% upside for Genfit in premarket analyst action
CymaBay Therapeutics Inc.
Genfit SA (OTCPK:GNFTF) initiated with Buy rating and a €46 (144% upside) price target at B. Riley FBR citing an expected positive outcome from the Phase 3 RESOLVE-IT study evaluating elafibranor in NASH.
More news on: Genfit, CymaBay Therapeutics, Vertex Pharmaceuticals Incorporated, Healthcare stocks news, Stocks on the move, ,